ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

An update on the role of TRIM/NLRP3 signaling pathway in atherosclerosis

Liu, Sibo; Bi, Hongfeng; Jiang, Meiling; Chen, Yuanli; Jiang, Meixiu*南昌大学
Biomedicine and Pharmacotherapy2023-4DOI: 10.1016/j.biopha.2023.114321
1被引11阅读
引用收藏
分享

摘要

Atherosclerosis (AS) is a chronic inflammatory disease of large and medium arteries that includes lipid metabolism disorder and recruitment of immune cells to the artery wall. An increasing number of studies have confirmed that inflammasome over-activation is associated with the onset and progression of atherosclerosis. The NLRP3 inflammasome, in particular, has been proven to increase the incidence rate of cardiovascular diseases (CVD) by promoting pro-inflammatory cytokine release and reducing plaque stability. The strict control of inflammasome and prevention of excessive inflammatory reactions have been the research focus of inflammatory diseases. Tripartite motif (TRIM) is a protein family with a conservative structure and rapid evolution. Several studies have demonstrated the TRIM family's regulatory role in mediating inflammation. This review aims to clarify the relationship between TRIMs and NLRP3 inflammasome and provide insights for future research and treatment discovery.

学科与关键词

关键词
AtherosclerosisNLRP3 inflammasomeTRIM family
相关
加载中…
  • Regulation of toll-like receptor (TLR) signaling pathways in atherosclerosis: from mechanisms to targeted therapeutics
    Jin, Mei; Fang, Jian; Wang, Jiao-jiao; Shao, Xin; Xu, Suo-wen; Liu, Pei-qing*; Ye, Wen-cai*; Liu, Zhi-ping*Acta Pharmacologica Sinica, 2023, 44(12): 2358-2375.被引 3
  • Negative Correlation between Serum NLRP3 and the Ratio of Treg/Th17 in Patients with Obstructive Coronary Artery Disease
    Fan, ZhiXing; Huang, YiFan; Wu, JinChun; Yang, ChaoJun; Guo, Xin; Du, Linghui; Yang, Jian*Reviews in Cardiovascular Medicine, 2022, 23(12).
  • The Molecular Pathways of Pyroptosis in Atherosclerosis
    Song, Dan; Li, Manman; Yu, Xue; Wang, Yuqin; Fan, Jiaying; Yang, Wei; Yang, Liming*; Li, Hong*Frontiers in Cell and Developmental Biology, 2022, 10: 824165.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
Biomedicine and Pharmacotherapy
发表日期
2023-04
卷期
第 160 卷
页码
114321
DOI
10.1016/j.biopha.2023.114321
语言
MULTI-LANGUAGE
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82200509, 82160094]; Jiangxi Provincial Department of Science and Technology, China [20202BAB206087]

作者

  • L

    Liu, Sibo (第一作者)

    nanchang univ

  • B

    Bi, Hongfeng

查看全部 5 位作者收起作者
  • J

    Jiang, Meiling

  • C

    Chen, Yuanli

  • J

    Jiang, Meixiu (通讯)

    nanchang univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417